Christine O'Connor, NP
Family · Norwalk, CTNPI 1164765921
Payments from drug & device makers
Across 155 payments — averaging $32.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genmab U.S., Inc.$2K
- AbbVie$533
- Bristol Myers Squibb$470
- Incyte Corporation$201
- Johnson & Johnson$192
- Eisai Inc.$157
- plus $2K from 31 others
What the payments were for
- Consulting fees$73115%
- Travel & lodging$83017%
- Food & beverage$3,16063%
- Education$2976%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genmab U.S., Inc. | 5 | $1,686 |
| AbbVie | 16 | $533 |
| Bristol Myers Squibb | 32 | $470 |
| Incyte Corporation | 7 | $201 |
| Johnson & Johnson | 7 | $192 |
| Eisai Inc. | 7 | $157 |
| Astellas Pharma US Inc | 3 | $136 |
| AstraZeneca | 5 | $126 |
| Genentech USA, Inc. | 6 | $126 |
| Lilly USA, LLC | 5 | $116 |
| Novartis | 4 | $105 |
| Pfizer | 5 | $94 |
| EMD Serono, Inc. | 3 | $86 |
| Pharmaessentia USA Corporation | 3 | $74 |
| Rigel Pharmaceuticals, Inc. | 3 | $74 |
| Jazz Pharmaceuticals Inc. | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| Sobi, Inc | 3 | $62 |
| Bayer | 3 | $51 |
| Stemline Therapeutics Inc. | 3 | $51 |
| AVEO Pharmaceuticals, Inc. | 3 | $49 |
| Coherus Oncology, Inc. | 3 | $48 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $44 |
| ADC Therapeutics America, Inc. | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Amgen | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Legend Biotech USA Inc. | 2 | $35 |
| Daiichi Sankyo Inc. | 2 | $35 |
| GSK | 1 | $26 |
| Array Biopharma Inc | 1 | $25 |
| Taiho Oncology, Inc. | 1 | $21 |
| Biocon Biologics Inc | 1 | $20 |
| Clovis Oncology, Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $18 |
| Sanofi | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPKINLY$1,686
How this compares
$5,018 in reported general payments places this provider in the 90th percentile of 1,596 family providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 28 | $1,261 |
| Prochlorperazine Maleate | 37 | $742 |
| Dexamethasone | 14 | $102 |
Paid to pharmacies, not to this prescriber.
Other family in Norwalk
- Patricia GartonNorwalk$16K
- Carla ReynoldsNorwalk$10K
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Dayna GiordanoNew Haven$65K
- Diana BytyqiDerby$53K
- Farhiya AbdiSouth Windsor$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.